Affective preclinical modeling of psychiatric disorders: Taking imbalanced primal emotional feelings of animals seriously in our search for novel antidepressants

Dialogues in Clinical Neuroscience

Volumn 17, Issue 4, 2015, Pages 363-379

  Panksepp, Jaak ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Antidepressant agent; Buprenorphine; Deep brain stimulation; Emotional affective behavior; Medial forebrain bundle; Primary process; Secondary process; Tertiary process

Indexed keywords

ANTIDEPRESSANT AGENT; BUPRENORPHINE;

AROUSAL; ARTICLE; DEPRESSION; DRUG SAFETY; EMOTION; EMOTIONAL DISORDER; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; IMBALANCED PRIMAL EMOTIONAL FEELINGS; LIFE; MENTAL DISEASE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SEMANTICS; ANIMAL; BIOLOGICAL MODEL; BRAIN; BRAIN DEPTH STIMULATION; DRUG EFFECTS; MENTAL DISORDERS; PHYSIOLOGY; PROCEDURES;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEEP BRAIN STIMULATION; EMOTIONS; HUMANS; MENTAL DISORDERS; MODELS, BIOLOGICAL;

EID: 84958949577     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Panksepp J. The vicissitudes of preclinical psychiatric research: justified abandonment by big pharma? Future Neurol. 2012;7(2):113-115.
2. LeDoux J. Rethinking the emotional brain. Neuron. 2012;73(4):653-676.
3. Markou A. Animal models of depression and antidepressant activity. Neurosci Biobehav Rev. 2005;29(4-5):501.
4. Panksepp J. Affective neuroscience of the emotional BrainMind: evolutionary perspectives and implications for understanding depression. Dialogues Clin Neurosci. 2010;12(4):533-545.
5. Watson JB. Behaviorism. New York, NY: W. W. Norton; 1929.
6. Skinner BF. Science and Human Behavior. New York, NY: Simon & Schuster; 1953:60.
7. Tinbergen N. The Study of Instinct. New York, NY: Oxford University Press; 1951:15.
8. Dawkins MS. Why Animals Matter: Animal Consciousness, Animal Welfare, and Human Well-being. Oxford, UK: Oxford University Press; 2012.
9. Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol. 1954;47(6):419-427.
10. Delgado JM, Roberts WW, Miller NE. Learning motivated by electrical stimulation of the brain. Am J Physiol. 1954;179(3):587-593.
11. Panksepp J. Hypothalamic integration of behavior: rewards, punishments, and related psychobiological process. In: Morgane PJ, Panksepp J, eds. Handbook of the Hypothalamus; vol 3, part A: .Behavioral Studies of the Hypothalamus. New York, NY: Marcel Dekker; 1981:289-487.
12. Heath R. Exploring the Mind-Body Relationship. Baton Rouge, LA: Moran Printing; 1996.
13. Panksepp J. Mood changes. In: Vinken P, Bruyn G, Klawans H, eds. Handbook of Clinical Neurology. vol 45. Amsterdam, the Netherlands: Elsevier; 1985:271-285.
14. Panksepp J. Toward a general psychobiological theory of emotions. Behav Brain Sci. 1982;5:407-422.
15. Panksepp J. Affective Neuroscience: The Foundations of Human and Animal Emotions. New York, NY: Oxford University Press; 1998.
16. Rolls ET. Emotion and Decision-Making Explained. Oxford, UK: Oxford University Press; 2014.
17. Rolls ET. Emotion and decision-making explained: response to commentators. Cortex. 2015;62:203-210.
18. Merker B. Consciousness without a cerebral cortex: a challenge for neuroscience and medicine. Behav Brain Sci. 2007;30:63-134.
19. Panksepp J. Emotional endophenotypes in evolutionary psychiatry. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(5):774-784.
20. Panksepp J, Biven L. Archaeology of Mind. New York, NY: Norton; 2011.
21. Liotti M, Panksepp J. On the neural nature of human emotions and implications for biological psychiatry. In: Panksepp J, ed. Textbook of Biological Psychiatry. Hoboken, NJ: Wiley; 2004:33-74.
22. Brady JV, Nauta WJ. Subcortical mechanisms in emotional behavior:the duration of affective changes following septal and habenular lesions in the albino rat. J Comp Physiol Psychol. 1955;48(5):412-420.
23. Panksepp J. Toward the constitution of emotional feelings: synergistic lessons from Izard's differential emotions theory and affective neuroscience. Emotion Rev 2015:7(2):110-115.
24. Northoff G, Schneider F, Rotte M, et al. Differential parametric modulation of self-relatedness and emotions in different brain regions. Human Brain Mapping. 2009;30(2):369-382.
25. Damasio AR, Grabowski TJ, Bechara A, et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci. 2000;3(10):1049-1056.
26. Zubieta JK, Ketter TA, Bueller JA, et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry. 2003;60(11):1145-1153.
27. Panksepp J, Normansell LA, Herman B, et al. Neural and neurochemical control of the separation distress call. In: Newman JD, ed. The Physiological Control of Mammalian Vocalizations. New York, NY: Plenum; 1988:263-300.
28. Panksepp J. Cross-species affective neuroscience decoding of the primal affective experiences of humans and related animals. PLoS One. 2011;6(9):e21236.
29. Hubel DH, Wiesel TN. Receptive fields, binocular interaction and functional architecture in the cat's visual cortex. J Physiol. 1962;160:106-154.
30. Sur M, Rubinstein JL. Patterning and plasticity of the cerebral cortex. Science. 2005;310(5749):805-810.
31. Florio M, Albert M, Taverna E, et al. Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion. Science. 2015;347(6229):1465-1470.
32. Lane RD, Ryan L, Nadel L, Greenberg L. Memory reconsolidation, emotional arousal, and the process of change in psychotherapy: new insights from brain science. Behav Brain Sci. 2015;38:e1.
33. Solms M. The Feeling Brain. London, UK: Karnac Books; 2015.
34. Solms M, Panksepp J. The "id" knows more than the "ego" admits:neuropsychoanalytic and primal consciousness perspectives on the interface between affective and cognitive neuroscience. Brain Sci. 2012;2(2):147-175.
35. Panksepp J, Normansell LA, Cox JF, Siviy S. Effects of neonatal decortication on the social play of juvenile rats. Physiol Behav. 1994;56(3):429-443.
36. LeGros Clark WE, Beattie J, Riddoch G, Dott NM. The Hypothalamus:Morphological, Functional, Clinical and Surgical Aspects. Edinburgh, UK: Oliver & Boyd; 1938.
37. Ikemoto S, Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward seeking. Brain Res Rev. 1999;31:6-41.
38. Wright JS, Panksepp J. Toward affective circuit-based preclinical models of depression: sensitizing dorsal PAG arousal leads to sustained suppression of positive affect in rats. Neurosci Biobehav Rev. 2011;35(9):1902-1915.
39. Watt DF, Panksepp J. Depression: an evolutionarily conserved mechanism to terminate separation-distress? A review of aminergic, peptidergic, and neural network perspectives. Neuropsychoanalysis. 2009;11(1):5-104.
40. Panksepp J, Wright JS, Döbrössy MD, Schlaepfer TE, Coenen VA. Affective neuroscience strategies for understanding and treating depressions:from preclinical models to novel therapeutics. Clin Psychol Sci. 2014;2(4):472-494.
41. Panksepp J, Yovell Y. Preclinical modeling of primal emotional affects (SEEKING, PANIC and PLAY): gateways to the development of new treatments for depression. Psychopathology. 2014;47(6):383-393.
42. Bowlby J. Loss: Sadness and Depression. London, UK: Hogarth Press; 1980. Attachment and Loss. Vol 3.
43. Panksepp J, Herman B, Conner R, Bishop P, Scott, JP. The biology of social attachments: opiates alleviate separation distress. Biol Psychiatr. 1978;13(5):607-618.
44. Herman BH, Panksepp J. Ascending endorphinergic inhibition of distress vocalization. Science. 1981;211(4486):1060-1062.
45. Panksepp J, Herman BH, Vilberg, T, Bishop P, DeEskinazi FG. Endogenous opioids and social behavior. Neurosci Biobehav Rev. 1980;4(4):473-487.
46. Tenore PL. Psychotherapeutic benefits of opioid agonist therapy. J Addict Dis 2008:27(3):49-65.
47. Bodkin JA, Zornberg GL, Lukas SE, Cole JO. Buprenorphine treatment of refractory depression. J Clin Psychopharmacol. 1995;15(1):49-57.
48. Yovell Y, Bar G, Mashiah M, et al. Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized, controlled trial. Am J Psychiatry. In press.
49. Panksepp J, Siviy S, Normansell LA. The psychobiology of play: theoretical and methodological perspectives. Neurosci Biobehav Rev. 1984;8(4):465-492.
50. Panksepp J, Beatty WW. Social deprivation and play in rats. Behav Neural Biol. 1980;30(2):197-206.
51. Panksepp J, Burgdorf J. 50k-Hz chirping (laughter?) in response to conditioned and unconditioned tickle-induced reward in rats: Effects of social housing and genetic variables. Behav Brain Res 2000:115(1):25-38.
52. Burgdorf J, Panksepp J, Brudzynski SM, Moskal JR. Breeding for 50- kHz positive affective vocalizations in rats. Behav Genet. 2005;35(1):67-72.
53. Burgdorf J, Panksepp J, Brudzynski SM, et al. The effects of selective breeding for differential rates of 50-kHz ultrasonic vocalizations on emotional behavior in rats. Dev Psychobiol. 2009;51(1):34-46.
54. Burgdorf J, Wood PL, Kroes RA, Moskal JR, Panksepp J. Neurobiology of 50-kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies. Behav Brain Res. 2007;182(2):274-283.
55. Burgdorf J, Panksepp J, Moskal JR. Frequency-modulated 50 kHz ultrasonic vocalizations: a tool for uncovering the molecular substrates of positive affect. Neurosci Biobehav Rev. 2011;35(9):1831-1836.
56. Burgdorf J, Kroes RA, Beinfeld MC, Panksepp J, Moskal JR. Uncovering the molecular basis of positive affect using rough-and-tumble play in rats:a role for insulin-like growth factor I. Neuroscience. 2010;168(3):769-777.
57. Moskal JR, Burch R, Burgdorf J, et al. GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists. Expert Opin Investig Drugs. 2014;23(2):243-254.
58. Normansell L, Panksepp J. Glutamatergic modulation of separation distress: profound emotional effects of excitatory amino acids in chicks. Neurosci Biobehav Rev. 2011;35(9):1890-1901.
59. Burgdorf J, Zhang XL, Nicholson KL, et al. GLYX-13, a NMDA receptor glycine- site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacol. 2013;38(5):729-742.
60. Preskorn S, Macaluso M, Mehra V, et al. Randomized proof of concept trial of GLYX-13, an N-Methyl-D-Aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent. J Psychiatr Pract. 2015;21(2):140-149.
61. Moskal JR, Burgdorf J, Kroes RA, Brudzynski SM, Panksepp J. A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism. Neurosci Biobehav Rev. 2011;35(9):1982-1988.
62. Panksepp J, Harro J. Future of neuropeptides in biological psychiatry and emotional psychopharmacology: goals and strategies. In: Panksepp J, ed. Textbook of Biological Psychiatry. Hoboken, NJ: Wiley-Liss; 2004:627-660.
63. Teitelbaum P, Epstein AN. The lateral hypothalamic syndrome: recovery of feeding and drinking after lateral hypothalamic lesions. Psychol Rev. 1962;69:74-90.
64. Coenen VA, Schlaepfer TE, Maedler B, Panksepp J. Cross-species affective functions of the medial forebrain bundle-implications for the treatment of affective pain and depression in humans. Neurosci Biobehav Rev. 2011;35(9):1971-1981.
65. Coenen VA, Panksepp J, Hurwitz TA, Urbach H, Mädler B. Human medial forebrain bundle (MFB) and anterior thalamic radiation (ATR): Diffusion tensor imaging of two major subcortical pathways that may promote a dynamic balance of opposite affects relevant for understanding depression. J Neuropsychiatry Clin Neurosci. 2012;24(2):223-236.
66. Schlaepfer TE, Bewernick B, Kayser S, Mädler B, Coenen VA. Rapid effects of deep brain stimulation for treatment resistant depression. Biol Psychiatr. 2013;73(12):1204-1212.
67. Panksepp J. Foreword: Perspectives on passages toward an affective neurobiology of mind? In: Koob GF, Le Moal M, Thompson RF, eds. Encyclopedia of Behavioral Neuroscience. Boston, MA: Elsevier Inc; 2010:i-viii.
68. Clarici A, Pellizzoni S, Guaschino S, et al. Intranasal administration of oxytocin in postnatal depression: implications for psychodynamic psychotherapy from a randomized double-blind pilot study. Front Psychol. 2015;6:426.
69. Kravitz AV, Bonci A. Optogenetics, physiology and emotions. Front Behav Neurosci. 2013;7:169.
70. Peciña M, Bohnert AS, Sikora M, et al. Association between placeboactivated neural systems and antidepressant responses: Neurochemistry of placebo effects in major depression. JAMA Psychiatry. 2015;72(11):1087-1094.